255
Participants
Start Date
July 26, 2019
Primary Completion Date
August 31, 2022
Study Completion Date
December 14, 2026
Crizanlizumab (SEG101)
"Crizanlizumab was supplied in single use 10 mL glass vials at a concentration of 10 mg/mL. One vial contains 100 mg of crizanlizumab. This is a concentrate for solution for infusion.~IV."
Placebo
Placebo was supplied in single use 10 mL glass vials at a concentration of 0 mg/mL. This is a concentrate for solution for infusion IV.
Novartis Investigative Site, Khoudh
Novartis Investigative Site, Brussels
Novartis Investigative Site, Brussels
Novartis Investigative Site, Tripoli
Novartis Investigative Site, Soweto
Novartis Investigative Site, Edegem
Novartis Investigative Site, Berlin
Novartis Investigative Site, Marseille
Novartis Investigative Site, Genova
Novartis Investigative Site, Milan
Novartis Investigative Site, Irbid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Levine Cancer Insitute Carolinas Healthcare System, Charlotte
Childrens Healthcare of Atlanta, Atlanta
Novartis Investigative Site, Verona
Univ of Tenn Health Sciences Ctr, Memphis
Novartis Investigative Site, Essen
Novartis Investigative Site, Cologne
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Paris
University of Texas Health Science Center at Houston, Houston
Novartis Investigative Site, Napoli
Novartis Investigative Site, Créteil
Novartis Investigative Site, Montería
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Bhubaneswar
Novartis Investigative Site, Valledupar
Boston Medical Center, Boston
Novartis Investigative Site, Salvador
Novartis Investigative Site, Belém
Novartis Investigative Site, Recife
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, Ribeirão Preto
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Accra
Novartis Investigative Site, Athens
Novartis Investigative Site, Pátrai
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Beirut
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, The Hague
Novartis Investigative Site, Panama City
Novartis Investigative Site, Panama City
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Adana
Novartis Investigative Site, Sheffield
Novartis Investigative Site, Cambridge
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Sheffield
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY